Recent developments in cancer care continue to offer promise for patients. Investigators are actively exploring cutting-edge approaches, including immune therapies , targeted treatments , and individualized healthcare . A key finding published this week showcases the effectiveness of a experimental drug in treating late-stage non-small cell lung ca